Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy

Mark S. Slaughter(University of Louisville), Francis D. Pagani(Michigan Medicine), Stuart D. Russell(Duke Medical Center), Kartik S. Sundareswaran(Thoratec Corporation (United States)), Ranjit John(University of Minnesota), Keith D. Aaronson(University of Michigan), Yoshifumi Naka(Cornell University), Andrew Boyle(Thomas Jefferson University), David J. Farrar(JTEC Corporation (Japan)), John V. Conte(Commonwealth Medical College)
The Journal of Heart and Lung Transplantation
April 19, 2010
10.1016/j.healun.2010.02.003
Cited by 141

Related Papers

Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
|The Lancet|2020|1k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655